Novel anthracycline-spacer-β-glucuronide, -β-glucoside, and -β-galactoside prodrugs for application in selective chemotherapy
- 1 August 1999
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 7 (8) , 1597-1610
- https://doi.org/10.1016/s0968-0896(99)00095-4
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The Role of β-Glucuronidase in Drug Disposition and Drug Targeting in HumansClinical Pharmacokinetics, 1997
- Glucuronide prodrugs of hydroxy compounds for antibody directed enzyme prodrug therapy (ADEPT) : A phenol nitrogen mustard carbamateBioorganic & Medicinal Chemistry Letters, 1997
- An Approach Towards More Selective Anticancer AgentsSynthesis, 1996
- Prodrugs of anticancer agentsAdvanced Drug Delivery Reviews, 1996
- Improved Characteristics of a Human β-Glucuronidase−Antibody Conjugate after Deglycosylation for Use in Antibody-Directed Enzyme Prodrug TherapyBioconjugate Chemistry, 1996
- Synthesis and evaluation of novel daunomycin-phosphate-sulfate -β-glucuronide and -β-glucoside prodrugs for application in adeptBioorganic & Medicinal Chemistry Letters, 1995
- 5-Fluorouracil derivatives with serum protein binding potencies.CHEMICAL & PHARMACEUTICAL BULLETIN, 1989
- Facile and efficient syntheses of carboxylic anhydrides and amides using (trimethylsilyl)ethoxyacetyleneThe Journal of Organic Chemistry, 1986
- 2-Acyloxymethylbenzoic acids. Novel amine protective functions providing amides with the lability of estersThe Journal of Organic Chemistry, 1976
- Diphenylphosphoryl azide. New convenient reagent for a modified Curtius reaction and for peptide synthesisJournal of the American Chemical Society, 1972